Martin H. Huber Jr. - Oct 21, 2021 Form 4 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
President of R&D and CMO
Signature
/s/ Chris Frankenfield, attorney-in-fact for Martin Huber
Stock symbol
XLO
Transactions as of
Oct 21, 2021
Transactions value $
$0
Form type
4
Date filed
10/25/2021, 05:17 PM
Previous filing
Sep 17, 2021
Next filing
Jan 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +157K $0.00 157K Oct 21, 2021 Common Stock 157K $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was granted on October 21, 2021 and will begin to vest on November 1, 2021 and continue to vest in equal monthly installments thereafter until October 1, 2025.